Ascendis Pharma A (ASND) Shares Outstanding (Weighted Average) (2012 - 2026)

Ascendis Pharma A has disclosed Shares Outstanding (Weighted Average) across 15 years of filings, most recently posting $11.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $11.9 million, up 618.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (up 618.52% YoY), and the FY2025 annual result was $9.7 million, up 11.24% from the prior year.
• Shares Outstanding (Weighted Average) came in at $11.9 million for Q1 2026 at Ascendis Pharma A, up from $9.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $60.6 million in Q4 2023 to a low of $1.7 million in Q1 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $6.5 million (2024), against an average of $11.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 85.62% in 2024 and surged 618.52% in 2026, its largest moves.
• Ascendis Pharma A's Shares Outstanding (Weighted Average) stood at $57.2 million in 2022, then rose by 5.86% to $60.6 million in 2023, then sank by 85.62% to $8.7 million in 2024, then grew by 11.24% to $9.7 million in 2025, then climbed by 23.27% to $11.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $11.9 million (Q1 2026), $9.7 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.